APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopy Successful launch in Japan follows recent reimbursement approval Approvals across APAC including China and Australia broaden reach for patients GALWAY, Ireland and SYDNEY, Sept. 28, 2024 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the presentation […]
Category Archives: Pr Newswire
SHANGHAI, Sept. 28, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced it has received a notification letter dated September 26, 2024 (the “Notice”) from the staff of […]
TOKYO, Sept. 28, 2024 /PRNewswire/ — The Bangladesh Tourism Board is proud to participate in Tourism Expo Japan 2024, offering visitors a unique opportunity to experience the natural wonders and rich cultural heritage of Bangladesh. Held from September 26th to 29th, the event showcases the best of Bangladesh’s attractions, inviting travelers to explore this captivating […]
Jacobs retains its innovative, next-generation data solutions and digital technologies business Newly streamlined portfolio enables company to focus on distinct strategies in advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water DALLAS, Sept. 28, 2024 /PRNewswire/ — Jacobs (NYSE: J) announced today the completion of the spin-off of its Critical Mission Solutions […]
URUMQI, China, Sept. 28, 2024 /PRNewswire/ — Chanson International Holding (Nasdaq: CHSN) (the “Company” or “Chanson”), a provider of bakery, seasonal, and beverage products through its chain stores in China and the United States, today announced its unaudited financial results for the six months ended June 30, 2024. Mr. Gang Li, Chairman of the Board of Directors and Chief Executive […]
Pr Newswire
Lexicon to Present Phase 3 Trial Design for Sotagliflozin in Hypertrophic Cardiomyopathy (HCM) at Upcoming Medical Congress
27
Sep
Sep
Patient randomization is underway in SONATA-HCM clinical trial evaluating Lexicon’s novel dual SGLT1 and SGLT2 inhibitor in this underserved and growing patient population Study design intended to enable supplemental new drug application (sNDA) with a broad label in both obstructive and non-obstructive HCM THE WOODLANDS, Texas, Sept. 27, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. […]
27
Sep
Sep
Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET OCALA, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, Chief Executive Officer of AIM will participate in a Virtual Investor CEO […]
27
Sep
Sep
Boca Raton, FL, Sept. 27, 2024 (GLOBE NEWSWIRE) — 33 Medical, Inc., a leader in cutting-edge spinal health innovations, is proud to announce that its NuvoDisc® medical device has been awarded the prestigious 2024 Best Technology in Spine Award. This accolade recognizes the NuvoDisc® as a revolutionary advancement in the treatment of degenerative disc disease […]
27
Sep
Sep
Independent Board Member Tara Comonte Will Serve as Interim Chief Executive OfficerSima Sistani Will Step Down as CEO and Director NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today that WeightWatchers Board member Tara Comonte has been appointed Interim Chief Executive Officer. Ms. Comonte […]
Pr Newswire
ImPact Biotech Announces 50% Enrollment in Phase 3 ENLIGHTED Clinical Trial of Padeliporfin VTP in Low Grade Upper Tract Urothelial Cancer
27
Sep
Sep
Phase 3 ENLIGHTED study enrollment completion expected by first quarter of 2025 TEL AVIV, Israel, Sept. 27, 2024 (GLOBE NEWSWIRE) — ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid tumors, today announced that the Phase 3 ENLIGHTED (ENdoluminal LIGHT ActivatED) trial evaluating Padeliporfin […]